NewtekOne

NEWT · NASDAQ

$11.19+$0.26 (+2.38%)TodayMarket closed ·
Prev close $10.93

About NEWT

NewtekOne, Inc. is a financial holding company, which engages in the provision of business and financial solutions. The company is headquartered in Boca Raton, Florida and currently employs 572 full-time employees. The Company’s segments include Banking, Alternative Lending, NSBF and Payments. Its business and financial solutions include Banking (Newtek Bank, N.A. ), Business Lending, SBA Lending Solutions, Electronic Payment Processing, Accounts Receivable Financing and Inventory Financing, Insurance Solutions and Payroll and Benefits Solutions. In addition, the Company offers its clients the Technology Solutions (Cloud Computing, Data Backup, Storage and Retrieval, IT Consulting and Web Services) provided by Intelligent Protection Management Corp. (IPM.com). The Company’s lending solutions include term loans and revolving lines of credit. The Company’s insurance solutions include commercial insurance, personal insurance, employee benefits and life insurance.

Employees
572
Headquarters
Boca Raton, Florida
Listed
Mar 17, 1980
Sector
Financials
Industry
Financial Services

NEWT key statistics

Market cap
323.22M
Price-earnings ratio
4.95
Dividend yield
9.45%
Average volume
243.14K
Volume
216.75K
Open price
$11.03
High today
$11.32
Low today
$11.03
52 Week high
$15.69
52 Week low
$9.59

NewtekOne (NEWT) at a glance

As of Oct 20, 2026, NewtekOne (NEWT) shares are priced at $11.19, giving the company a market cap of 323.22M, a price-to-earnings ratio of 4.95 and a dividend yield of 9.45%.

Today the stock has traded between $11.03 and $11.32. The current price is 1.5% above the day's low and 1.1% below its high.

Volume so far is 216.75K shares, in line with the average of 243.14K shares a day.

Over the past year NewtekOne has ranged from $9.59 to $15.69, and now sits 26% of the way up that range.

NewtekOne met or beat analyst EPS estimates in 3 of the last 8 quarters. In Q2 FY26 it reported $0.47 per share against an estimate of $0.4852.

The average analyst price target is $16.12, 44.0% above the current price, from 3 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

33%of 3 analyst ratings say Buy
  • Buy33.3%
  • Hold66.7%
  • Sell0.0%
Price target · 7 analystsAvg $16.12
Low
$13.13
Now
$11.19
High
$22.05

NEWT earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 3 of the last 8 quarters, by 2.0% on average.

  1. Q3 FY24: reported $0.45 per share against an estimate of $0.4417
  2. Q4 FY24: reported $0.69 per share against an estimate of $0.6764
  3. Q1 FY25: reported $0.35 per share against an estimate of $0.3617
  4. Q2 FY25: reported -$0.70 per share against an estimate of $0.5353
  5. Q3 FY25: reported $0.67 per share against an estimate of $0.6553
  6. Q4 FY25: reported $0.65 per share against an estimate of $0.6953
  7. Q1 FY26: reported $0.43 per share against an estimate of $0.4471
  8. Q2 FY26: reported $0.47 per share against an estimate of $0.4852

NEWT news

  • Press releaseBusiness Wire

    KBRA Publishes Ratings for NewtekOne, Inc.

  • NewtekOne Reports Q2 2026 Results: Full Earnings Call Transcript

  • A Glimpse of NewtekOne's Earnings Potential

  • Avi Kapoor

    $1.8M Bet On Singular Genomics? Check Out These 3 Stocks Executives Are Buying

  • Avi Kapoor

    Wall Street's Most Accurate Analysts Weigh In On 3 Financials Stocks With Over 5% Dividend Yields

Similar companies

Companies in the same industry as NewtekOne

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.